Publications by authors named "A Jarjou'i"
Patients with coronavirus 2019 (COVID-19) and obstructive sleep apnoea (OSA) have a worse prognosis than COVID-19 patients without OSA. This study aimed to examine the relationship between OSA risk and the severity of COVID-19 in patients undiagnosed with OSA. Patients diagnosed with COVID-19 and hospitalized or admitted to a community hotel were recruited for the study after recovery during a clinic check-up visit 6-8 weeks after discharge.
View Article and Find Full Text PDFCOVID-19 patients are oftentimes over- or under-treated due to a deficit in predictive management tools. This study reports derivation of an algorithm that integrates the host levels of TRAIL, IP-10, and CRP into a single numeric score that is an early indicator of severe outcome for COVID-19 patients and can identify patients at-risk to deteriorate. 394 COVID-19 patients were eligible; 29% meeting a severe outcome (intensive care unit admission/non-invasive or invasive ventilation/death).
View Article and Find Full Text PDFBackground: COVID-19 severity and its late complications continue to be poorly understood. Neutrophil extracellular traps (NETs) form in acute COVID-19, likely contributing to morbidity and mortality.
Objectives: This study evaluated immunothrombosis markers in a comprehensive cohort of acute and recovered COVID-19 patients, including the association of NETs with long COVID.
Article Synopsis
- - The study tracked 166 COVID-19 patients to analyze the prevalence and duration of symptoms over 18 months after their diagnosis, finding a mean of 2.3 symptoms initially, decreasing to 1.8 at 3 months and 0.6 at 18 months post-recovery.
- - Some symptoms, like cough and loss of smell, significantly decreased after 3 months, while others like dyspnea (difficulty breathing) and weakness showed an increase during this time.
- - By 18 months, all symptoms had generally reduced, but dyspnea, weakness, and brain fog remained notably present, indicating that some issues may persist long after recovery and should be addressed in post-COVID care.